Abstract
Background
Whether the Oxford classification of immunoglobulin A nephropathy can be utilized to predict the adverse renal outcome of Henoch–Schonlein purpura nephritis (HSPN) has been long-debated. We, therefore, performed a meta-analysis to evaluate the prognostic value of Oxford classification lesions in HSPN.
Methods
We systematically searched Medline, EMBASE, Web of Science, and the Cochrane Library for articles published from January 1970 to August 2020. Cohort and case–control studies investigating the correlation between the Oxford classification and renal outcome were included, the quality of which was assessed by the Newcastle–Ottawa scale criteria. The pooled odds ratios (ORs) with their 95% confidence intervals (CIs) were calculated with a random-effects model or a fixed-effects model depending on the heterogeneity.
Results
A total of 485 papers were reviewed and eventually 9 comparisons were included, providing data of 1688 patients with HSPN. ORs for adverse renal events were 2.83 (95% CI 1.84–4.35; P < 0.001), 1.96 (95% CI 1.28–2.98; P < 0.05), and 5.45 (95% CI, 3.15–9.45; P < 0.001) for patients with lesions of endocapillary hypercellularity (E), segmental sclerosis (S), and tubular atrophy /interstitial fibrosis (T), respectively, without significant heterogeneity (E: I2 = 0.0%; P = 0.498; S: I2 = 22.4%; P = 0.258; T: I2 = 33.6%; P = 0.171). Subgroup analysis adjusted for age also supported the results that E, S, and T lesions could serve as poor predictors (P < 0.05). Additionally, crescents (C) were strongly associated with renal outcome (OR 2.22; 95% CI 1.62–3.04; P < 0.001), with moderate heterogeneity (I2 = 49.3%; P = 0.066). However, it should be noted that it is not the presence but the proportions of crescent lesions that were related to the high risk of progression to adverse renal events, because the predictability of lower rates of crescent (C1, with crescents > 0 and ≤ 25%) was uncertain (OR 2.21; 95% CI 0.75–6.51; P > 0.05). Although the pooled OR revealed that lesions of mesangial hypercellularity (M) were correlated with poor renal prognosis (OR 2.41; 95% CI 1.07–5.43; P < 0.05), subgroup analysis separating children from adults indicated that there seemed to be no significant difference.
Conclusions
Oxford classification, especially for E, S, T, and C, might be recommended for patients with HSPN, regardless of children and adults.
Similar content being viewed by others
References
Davin JC (2011) Henoch-Schonlein purpura nephritis: pathophysiology, treatment, and future strategy. Clin J Am Soc Nephrol 6:679–689. https://doi.org/10.2215/CJN.06710810
Pillebout E, Thervet E, Hill G, Alberti C, Vanhille P, Nochy D (2002) Henoch-Schonlein Purpura in adults: outcome and prognostic factors. J Am Soc Nephrol 13:1271–1278. https://doi.org/10.1097/01.asn.0000013883.99976.22
Coppo R, Andrulli S, Amore A, Gianoglio B, Conti G, Peruzzi L et al (2006) Predictors of outcome in Henoch-Schonlein nephritis in children and adults. Am J Kidney Dis 47:993–1003. https://doi.org/10.1053/j.ajkd.2006.02.178
Shrestha S, Sumingan N, Tan J, Alhous H, McWilliam L, Ballardie F (2006) Henoch Schonlein purpura with nephritis in adults: adverse prognostic indicators in a UK population. QJM: Mon J Assoc Physicians 99:253–265. https://doi.org/10.1093/qjmed/hcl034
Derham RJ (1977) Prognosis of Henoch-Schönlein nephritis in children. BMJ 2:262. https://doi.org/10.1136/bmj.2.6081.262-d
Jelusic M, Sestan M, Cimaz R, Ozen S (2019) Different histological classifications for Henoch-Schönlein purpura nephritis: which one should be used? Pediatr Rheumatol Online J 17:10. https://doi.org/10.1186/s12969-019-0311-z
Kiryluk K, Moldoveanu Z, Sanders JT, Eison TM, Suzuki H, Julian BA et al (2011) Aberrant glycosylation of IgA1 is inherited in both pediatric IgA nephropathy and Henoch-Schönlein purpura nephritis. Kidney Int 80:79–87. https://doi.org/10.1038/ki.2011.16
Davin JC, Ten Berge IJ, Weening JJ (2001) What is the difference between IgA nephropathy and Henoch-Schönlein purpura nephritis? Kidney Int 59:823–834. https://doi.org/10.1046/j.1523-1755.2001.059003823.x
Li X, Tang M, Yao X, Zhang N, Fan J, Zhou N et al (2019) A clinicopathological comparison between IgA nephropathy and Henoch-Schönlein purpura nephritis in children: use of the Oxford classification. Clin Exp Nephrol 23:1382–1390. https://doi.org/10.1007/s10157-019-01777-8
Davin JC, Ten Berge IJ, Weening JJ (2001) What is the difference between IgA nephropathy and Henoch-Schonlein purpura nephritis? Kidney Int 59:823–834. https://doi.org/10.1046/j.1523-1755.2001.059003823.x
Shamseer L, Moher D, Clarke M, Ghersi D, Liberati A, Petticrew M, Shekelle P, Stewart LA; PRISMA-P Group (2016) Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ 350:g7647. https://doi.org/10.1136/bmj.g7647
Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D et al (2000) Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group. JAMA 283:2008–2012. https://doi.org/10.1001/jama.283.15.2008
Cattran DC, Coppo R, Cook HT, Feehally J, Roberts IS, Troyanov S et al (2009) The Oxford classification of IgA nephropathy: rationale, clinicopathological correlations, and classification. Kidney Int 76:534–545. https://doi.org/10.1038/ki.2009.243
Haas M, Verhave JC, Liu ZH, Alpers CE, Barratt J, Becker JU et al (2017) A multicenter study of the predictive value of crescents in IgA nephropathy. J Am Soc Nephrol 28:691–701. https://doi.org/10.1681/asn.2016040433
Wells GA, Shea BJ, O’Connell D et al. The Newcastle-Ottawa scale (NOS) for assessing the quality of non-randomized studies in meta-analysis. http://www.ohri.ca/programs/clinical_epidemiology/oxford.asp. Accessed 26 June 2020.
Inagaki K, Kaihan AB, Hachiya A, Ozeki T, Ando M, Kato S et al (2018) Clinical impact of endocapillary proliferation according to the Oxford classification among adults with Henoch-Schonlein purpura nephritis: a multicenter retrospective cohort study. BMC Nephrol 19:208. https://doi.org/10.1186/s12882-018-1009-z
Huang X, Wu J, Wu XM, Hao YX, Zeng CH, Liu ZH et al (2018) Significance of histological crescent formation in patients with IgA vasculitis (Henoch-Schonlein purpura)-related nephritis: a cohort in the adult Chinese population. BMC Nephrol 19:334. https://doi.org/10.1186/s12882-018-1117-9
Huang XH, Ma L, Ren P, Wang H, Chen L, Han H et al (2019) Updated Oxford classification and the international study of kidney disease in children classification: application in predicting outcome of Henoch-Schonlein purpura nephritis. Diagn Pathol 14:40. https://doi.org/10.1186/s13000-019-0818-0
Kim CH, Lim BJ, Bae YS, Kwon YE, Kim YL, Nam KH et al (2014) Using the Oxford classification of IgA nephropathy to predict long-term outcomes of Henoch-Schonlein purpura nephritis in adults. Modern Pathol: Off J United States Can Acad Pathol, Inc 27:972–982
Zhong ZX, Tan JX, Tang Y, Tan L, Pei GQ, Qin W (2019) Crescent lesions are not a predictive factor in adult-onset Henoch-Schonlein purpura nephritis. Clin Exp Med. https://doi.org/10.1007/s10238-019-00567-6
Xu K, Zhang L, Ding J, Wang S, Su B, Xiao H et al (2018) Value of the Oxford classification of IgA nephropathy in children with Henoch-Schonlein purpura nephritis. J Nephrol 31:279–286. https://doi.org/10.1007/s40620-017-0457-z
Cakici EK, Gur G, Yazilitas F, Eroglu FK, Gungor T, Arda N et al (2019) A retrospective analysis of children with Henoch-Schonlein purpura and re-evaluation of renal pathologies using Oxford classification. Clin Exp Nephrol 23:939–947. https://doi.org/10.1007/s10157-019-01726-5
Yun D, Kim DK, Oh KH, Joo KW, Moon KC, Kim YS et al (2020) MEST-C pathological score and long-term outcomes of child and adult patients with Henoch-Schonlein purpura nephritis. BMC Nephrol 21:33. https://doi.org/10.1186/s12882-020-1691-5
Lu S, Liu D, Xiao J, Yuan W, Wang X, Zhang X et al (2015) Comparison between adults and children with Henoch-Schönlein purpura nephritis. Pediatric Nephrology (Berlin, Germany) 30:791–796. https://doi.org/10.1007/s00467-014-3016-z
Rieu P, Noël LH (1999) Henoch-Schönlein nephritis in children and adults. Morphological features and clinicopathological correlations. Ann Med Interne 150:151–159
Rostoker G (2001) Schonlein-henoch purpura in children and adults: diagnosis, pathophysiology and management. BioDrugs: Clini Immunotherapeut Biopharmaceut Gene Ther 15:99–138. https://doi.org/10.2165/00063030-200115020-00004
Lv J, Shi S, Xu D, Zhang H, Troyanov S, Cattran DC et al (2013) Evaluation of the Oxford Classification of IgA nephropathy: a systematic review and meta-analysis. Am J Kidney Dis 62:891–899. https://doi.org/10.1053/j.ajkd.2013.04.021
Chakera A, MacEwen C, Bellur SS, Chompuk LO, Lunn D, Roberts ISD (2016) Prognostic value of endocapillary hypercellularity in IgA nephropathy patients with no immunosuppression. J Nephrol 29:367–375. https://doi.org/10.1007/s40620-015-0227-8
Szeto CC, Choi PC, To KF, Li PK, Hui J, Chow KM et al (2001) Grading of acute and chronic renal lesions in Henoch-Schönlein purpura. Modern Pathol:Off J United States Can Acad Pathol, Inc 14:635–640. https://doi.org/10.1038/modpathol.3880364
Coppo R, Troyanov S, Bellur S, Cattran D, Cook HT, Feehally J et al (2014) Validation of the Oxford classification of IgA nephropathy in cohorts with different presentations and treatments. Kidney Int 86:828–836. https://doi.org/10.1038/ki.2014.63
Shi SF, Wang SX, Jiang L, Lv JC, Liu LJ, Chen YQ et al (2011) Pathologic predictors of renal outcome and therapeutic efficacy in IgA nephropathy: validation of the oxford classification. Clinical journal of the American Society of Nephrology : CJASN 6:2175–2184. https://doi.org/10.2215/cjn.11521210
Alamartine E, Sauron C, Laurent B, Sury A, Seffert A, Mariat C (2011) The use of the Oxford classification of IgA nephropathy to predict renal survival. Clinical journal of the American Society of Nephrology : CJASN 6:2384–2388. https://doi.org/10.2215/cjn.01170211
Shao X, Li B, Cao L, Liang L, Yang J, Wang Y et al (2017) Evaluation of crescent formation as a predictive marker in immunoglobulin A nephropathy: a systematic review and meta-analysis. Oncotarget 8:46436–46448. https://doi.org/10.18632/oncotarget.17502
Lv J, Yang Y, Zhang H, Chen W, Pan X, Guo Z et al (2013) Prediction of outcomes in crescentic IgA nephropathy in a multicenter cohort study. J Am Soc Nephrol 24:2118–2125. https://doi.org/10.1681/asn.2012101017
Rianthavorn P, Chacranon M (2018) Long-term renal outcome in pediatric glomerulonephritis associated with crescent formation. Clin Exp Nephrol 22:661–667. https://doi.org/10.1007/s10157-017-1498-2
Zhang X, Shi S, Ouyang Y, Yang M, Shi M, Pan X et al (2018) A validation study of crescents in predicting ESRD in patients with IgA nephropathy. J Transl Med 16:115. https://doi.org/10.1186/s12967-018-1488-5
Peng W, Tang Y, Tan L, Qin W (2019) Crescents and Global Glomerulosclerosis in Chinese IgA Nephropathy Patients: A Five-Year Follow-Up. Kidney Blood Press Res 44:103–112. https://doi.org/10.1159/000498874
Funding
This research received no funding from any organization nor individual.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interest in this manuscript.
Research involving human and animal participants
No human and animal participants were involved in this study.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
Luo, X., Tan, J., Wan, D. et al. Predictability of the Oxford classification of IgA nephropathy in Henoch–Schonlein purpura nephritis. Int Urol Nephrol 54, 99–109 (2022). https://doi.org/10.1007/s11255-021-02861-3
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11255-021-02861-3